Showing results (491-500 of 1,835) with videos related to

Sort By:
Pageof 184
ESMO Open|November 3, 2022
Bone metastases are associated with worse prognosis in patients affected by metastatic colorectal cancer treated with doublet or triplet chemotherapy plus bevacizumab: a subanalysis of the TRIBE and TRIBE2 trialsE Dell'Aquila, D Rossini, C A M Fulgenzi, et al.
ESMO Open|September 24, 2022
Addition of androgen receptor-targeted agents to androgen-deprivation therapy and docetaxel in metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysisB A Maiorano, U De Giorgi, G Roviello, et al.
ESMO Open|September 26, 2022
Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trialE D Capoluongo, B Pellegrino, L Arenare, et al.
ESMO Open|January 8, 2022
Targeting immunoliposomes to EGFR-positive glioblastomaB Kasenda, D König, M Manni, et al.
ESMO Open|April 10, 2019
Development of sodium fluoride PET response criteria for solid tumours (NAFCIST) in a clinical trial of radium-223 in osteosarcoma: from RECIST to PERCIST to NAFCISTKalevi Kairemo, Eric M Rohren, Pete M Anderson, et al.
ESMO Open|August 11, 2018
Real-world features associated with cancer-related venous thromboembolic eventsMaija Helena Peippo, Samu Kurki, Riitta Lassila, et al.
ESMO Open|August 11, 2018
PHOTOSTENT-02: porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with locally advanced or metastatic biliary tract cancerStephen P Pereira, Mark Jitlal, Marian Duggan, et al.
ESMO Open|August 11, 2018
Phase II study assessing the benefit of cisplatin re-introduction (stop-and-go strategy) in patients with advanced non-squamous non-small cell lung cancer: the IFCT-1102 BUCiL study (a Better Use of Cisplatin in Lung cancer)Jaafar Bennouna, Fabrice Barlesi, Pascal Do, et al.
ESMO Open|April 24, 2018
BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancerJan Norum, Eli Marie Grindedal, Cecilie Heramb, et al.
ESMO Open|October 22, 2021
The prognostic and predictive impact of low estrogen receptor expression in early breast cancer: a systematic review and meta-analysisN-M Paakkola, A Karakatsanis, D Mauri, et al.
Pageof 184